Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 127 | 0.330 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.250 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 16 | 0.240 |
Why?
|
| Adenoma | 1 | 2005 | 60 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 37 | 0.200 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cryosurgery | 2 | 2013 | 24 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 35 | 0.130 |
Why?
|
| Scoliosis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 93 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2015 | 33 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2015 | 39 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2015 | 59 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 26 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 58 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 4 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 300 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2013 | 33 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 24 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 13 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 42 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 443 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Optic Disk | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 4 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 15 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2012 | 12 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 102 | 0.100 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 4 | 0.090 |
Why?
|
| Humans | 13 | 2016 | 27074 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 12 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 1 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 350 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 406 | 0.080 |
Why?
|
| Female | 9 | 2016 | 15213 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 8997 | 0.080 |
Why?
|
| Adult | 6 | 2016 | 7831 | 0.080 |
Why?
|
| Male | 9 | 2016 | 14772 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2016 | 457 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 25 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 3 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 12 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 161 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 35 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2016 | 3538 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 370 | 0.070 |
Why?
|
| Middle Aged | 6 | 2014 | 8923 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 92 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 348 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 243 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Adolescent | 2 | 2016 | 2172 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 35 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3485 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 193 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 120 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 29 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 133 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 552 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 482 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 366 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1112 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4777 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 1649 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 673 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 172 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 2109 | 0.030 |
Why?
|
| Aging | 1 | 2006 | 1544 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2016 | 84 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 26 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 11 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 121 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 147 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 57 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 17 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 34 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 42 | 0.030 |
Why?
|
| China | 1 | 2014 | 46 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 213 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 83 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 134 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 44 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 37 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 175 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 107 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 63 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1368 | 0.020 |
Why?
|
| Child | 1 | 2016 | 1295 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 520 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 222 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 141 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 110 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 37 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 56 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 80 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 458 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 69 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 333 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 114 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 3 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 6 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 11 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1395 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 30 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 47 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 1994 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 162 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 12 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 395 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 11 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 29 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1433 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 81 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 23 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 12 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 21 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 37 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 21 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 109 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 120 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 195 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 201 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 147 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 220 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 143 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 137 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 342 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 363 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 324 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3642 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 785 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 562 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 125 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 2302 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 560 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 670 | 0.010 |
Why?
|